Tuberville, Paul Crack Down on Harmful FDA Rule
May 21, 2024
May 21, 2024
WASHINGTON, May 21 -- Sen. Tommy Tuberville, R-Alabama, issued the following news release:
Senator Tommy Tuberville (R-AL) joined U.S. Senator Rand Paul (R-KY) in a resolution of disapproval under the Congressional Review Act (CRA) to oppose the Medical Devices: Laboratory Developed Tests (LDTs) rule that was recently finalized by the Food and Drug Administration (FDA). The final rule, published May 6th, seeks to impose burdensome regulations on the creation and implementation of LD . . .
Senator Tommy Tuberville (R-AL) joined U.S. Senator Rand Paul (R-KY) in a resolution of disapproval under the Congressional Review Act (CRA) to oppose the Medical Devices: Laboratory Developed Tests (LDTs) rule that was recently finalized by the Food and Drug Administration (FDA). The final rule, published May 6th, seeks to impose burdensome regulations on the creation and implementation of LD . . .